LRP4 and amyotrophic lateral sclerosis: According to Huijbers et al., anti-LRP4-ab testing in ALS patients may be considered in patients with prominent bulbar weakness, prolonged disease course, minor fluctuations and absence of upper motor neuron involvement (49).